Increased circulating sclerostin levels in rheumatoid arthritis patients: an updated meta-analysis; [Erhöhte Werte für zirkulierendes Sclerostin bei Patienten mit rheumatoider Arthritis: aktualisierte Metaanalyse]

被引：0
作者：
Mao Y.-M. [1 ,2 ]
Liao T. [1 ,2 ]
Ye Q.-L. [3 ]
Wu G.-C. [4 ]
Zhang Q. [1 ,2 ]
Tao S.-S. [1 ,2 ]
Zhao C.-N. [1 ,2 ]
Wu Q. [1 ,2 ]
Dan Y.-L. [1 ,2 ]
Pan H.-F. [1 ,2 ]
Ye D.-Q. [1 ,2 ]
机构：
[1] Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Anhui, Hefei
[2] Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, 81 Meishan Road, Anhui, Hefei
[3] Department of Hematology, The Second Hospital, Anhui Medical University, Anhui, Hefei
[4] School of Nursing, Anhui Medical University, 15 Feicui Road, Anhui, Hefei
来源：
Zeitschrift für Rheumatologie | 2023年 / 82卷 / Suppl 1期
基金：
中国国家自然科学基金;
关键词：
Autoimmune disease; Biomarker; Meta-analysis; Rheumatoid arthritis; Sclerostin;
D O I：
10.1007/s00393-021-01091-3
中图分类号：
学科分类号：
摘要：
Background: Sclerostin, a regulator of bone metabolism and vascular calcification involved in regulating the Wnt/β-catenin signaling pathway, has been shown to be involved in the pathogenesis of rheumatoid arthritis (RA). However, current results regarding the circulating sclerostin level of RA patients are debatable. This study aimed to evaluate the circulating level of sclerostin in RA patients and briefly summarize its role. Method: PubMed, EMBASE, and the Cochrane Library databases were systematically searched till May 27, 2021, for eligible articles. Useful data from all qualified papers were systematically extracted and analyzed using Stata 12.0 software (Stata Corp LP, College Station, TX, USA). Results: Overall, 13 qualifying studies including 1030 cases and 561 normal controls were analyzed in this updated meta-analysis. Forest plot of this meta-analysis showed that RA patients had higher circulating sclerostin levels (P < 0.001, standardized mean difference [SMD] = 0.916, 95% CI: 0.235–1.597) compared to normal controls. Subgroup analyses implied that age, region, and assay method were associated with sclerostin level in RA patients. Conclusion: RA patients have higher circulating sclerostin levels, and these was influenced by age, region, and assay method. © 2021, Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
引用
收藏
页码：51 / 58
页数：7
相关论文
共 43 条
[1]  
Boman A., Kokkonen H., Arlestig L., Et al., Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis, Clin Rheumatol, 36, pp. 1005-1012, (2017)
[2]  
Choi Y., Arron J.R., Townsend M.J., Promising bone-related therapeutic targets for rheumatoid arthritis, Nat Rev Rheumatol, 5, pp. 543-548, (2009)
[3]  
Delgado-Calle J., Sato A.Y., Bellido T., Role and mechanism of action of sclerostin in bone, Bone, 96, pp. 29-37, (2017)
[4]  
Dhakad U., Sahoo R., Goel A., Et al., Serum sclerostin levels in rheumatoid arthritis and correlation with disease activity and bone mineral density, Indian J Rheumatol, 14, pp. 28-31, (2019)
[5]  
Druce K.L., Jones G.T., Macfarlane G.J., Et al., Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis, Rheumatology, 54, pp. 964-971, (2015)
[6]  
Egger M., Davey Smith G., Schneider M., Et al., Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, pp. 629-634, (1997)
[7]  
El-Bakry S., Saber N., Zidan H., Et al., Sclerostin as an innovative insight towards understanding rheumatoid arthritis, Egypt Rheumatol, 38, pp. 71-75, (2016)
[8]  
Fassio A., Idolazzi L., Viapiana O., Et al., In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls, Clin Rheumatol, 36, pp. 2377-2381, (2017)
[9]  
Fayed A., Elgohary R., Fawzy M., Evaluating the role of serum sclerostin as an indicator of activity and damage in Egyptian patients with rheumatoid arthritis: university hospital experience, Clin Rheumatol, 39, pp. 1121-1130, (2020)
[10]  
Fulzele K., Dedic C., Lai F., Et al., Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity, Bone, 117, pp. 138-148, (2018)
12345